Bristol-Myers Squibb (United States)

Bristol-Myers Squibb (BMS) is a global biopharmaceutical company transforming patients’ lives through science. BMS leads in oncology, hematology, immunology, cardiovascular, and fibrotic diseases. Key products include Opdivo (nivolumab) and Yervoy (ipilimumab) for cancer immunotherapy, Revlimid (lenalidomide) and Pomalyst for multiple myeloma, Eliquis (apixaban) for blood clots and stroke prevention, and Orencia for rheumatoid arthritis. BMS’s innovative pipeline continues advancing breakthrough treatments for serious diseases.